Investor Ubs Asset Management Americas Inc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Ubs Asset Management Americas Inc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-11 13G AMRZ / Amrize AG 38,197,652
2025-07-17 13G MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) 2,144,607
2025-07-17 13G NVS / Novartis AG - Depositary Receipt (Common Stock) 139,602,467
2025-07-17 13G SNRE / Sunrise Communications AG - Depositary Receipt (Common Stock) 3,498,295
2025-04-25 13G/A CLX / The Clorox Company 10,794,027 1,081,801
2025-01-24 13G CLX / The Clorox Company 10,794,027
2025-01-24 13G/A LYFT / Lyft, Inc. 20,341,153 14,557,944
2025-01-24 13G/A LYFT / Lyft, Inc. 20,341,153 14,557,994
2024-10-04 13G/A SLM / SLM Corporation 12,265,852
2024-02-13 13G ALC / Alcon Inc. 25,782,426
2024-02-13 13G LOGI / Logitech International S.A. 8,436,708
2024-02-13 13G LYFT / Lyft, Inc. 20,341,153
2024-02-13 13G/A SLM / SLM Corporation 16,562,446 12,265,852
2024-02-13 13G/A MEG / Montrose Environmental Group, Inc. 2,362,771 2,491,944
2024-02-13 13G/A PRLD / Prelude Therapeutics Incorporated 2,507,992 0
2023-02-13 13G PRLD / Prelude Therapeutics Incorporated 2,507,992
2023-02-13 13G SLM / SLM Corporation 16,562,446
2023-02-13 13G/A MEG / Montrose Environmental Group, Inc. 2,405,620 2,362,771
2022-02-14 13G MEG / Montrose Environmental Group, Inc. 2,405,620
2022-02-14 13G/A CUK / Carnival Corporation & plc - Depositary Receipt (Common Stock) 9,813,464 6,184,921
2021-07-09 13G/A TAL / TAL Education Group - Depositary Receipt (Common Stock) 18,917,074 5,123,134
2021-07-09 13G/A BATRA / Atlanta Braves Holdings, Inc. 1,509,892 15,107
2021-02-12 13G CUK / Carnival Corporation & plc - Depositary Receipt (Common Stock) 9,813,464
2021-02-12 13G/A IRWD / Ironwood Pharmaceuticals, Inc. 11,181,451 1,935,957
2021-02-12 13G/A US451055AG27 / Iconix Brand Group Inc Bond 616,908 0
2021-02-12 13G/A BATRA / Atlanta Braves Holdings, Inc. 1,140,100 1,509,892
2021-02-12 13G/A TAL / TAL Education Group - Depositary Receipt (Common Stock) 17,203,377 18,917,074
2020-02-12 13G/A BATRA / Atlanta Braves Holdings, Inc. 1,241,525 1,140,100
2020-02-12 13G/A TAL / TAL Education Group - Depositary Receipt (Common Stock) 14,654,347 17,203,377
2020-02-12 13G/A US451055AG27 / Iconix Brand Group Inc Bond 804,799 616,908
2020-02-12 13G/A IRWD / Ironwood Pharmaceuticals, Inc. 8,591,679 11,181,451
2019-06-07 13G/A US451055AG27 / Iconix Brand Group Inc Bond 988,189 804,799
2019-04-11 13G/A US451055AG27 / Iconix Brand Group Inc Bond 988,189 988,189
2019-04-10 13G/A US451055AG27 / Iconix Brand Group Inc Bond 988,189
2019-04-02 13G/A BATRA / Atlanta Braves Holdings, Inc. 1,220,399 1,241,525
2019-02-13 13G/A LXRX / Lexicon Pharmaceuticals, Inc. 5,595,669 4,244,391
2019-02-13 13G/A TAL / TAL Education Group - Depositary Receipt (Common Stock) 10,407,912 14,654,347
2019-02-13 13G/A IRWD / Ironwood Pharmaceuticals, Inc. 7,632,959 8,591,679
2019-02-13 13G/A 451055107 / Iconix Brand Group Inc 11,270,489 11,265,289
2019-02-13 13G BATRA / Atlanta Braves Holdings, Inc. 1,220,399
2018-07-09 13G/A 451055107 / Iconix Brand Group Inc 15,482,168 11,270,489
2018-04-10 13G 451055107 / Iconix Brand Group Inc 15,482,168
2018-02-13 13G/A LXRX / Lexicon Pharmaceuticals, Inc. 42,605,050 5,595,669
2018-02-13 13G IRWD / Ironwood Pharmaceuticals, Inc. 7,632,959
2018-02-13 13G/A TAL / TAL Education Group - Depositary Receipt (Common Stock) 10,479,065 10,407,912
2017-07-13 13G/A EDU / New Oriental Education & Technology Group Inc. - Depositary Receipt (Common Stock) 18,950,228 0
2017-05-03 13G EDU / New Oriental Education & Technology Group Inc. - Depositary Receipt (Common Stock) 18,950,228
2017-01-20 13G/A LXRX / Lexicon Pharmaceuticals, Inc. 42,605,050 5,224,214
2017-01-20 13G/A CYOU / Changyou.com, Ltd. 1,345,058 1,054,550
2017-01-20 13G/A CMRX / Chimerix, Inc. 3,425,999 15,551
2017-01-20 13G/A SREV / ServiceSource International Inc 4,464,135 15,033
2017-01-20 13G/A 528872AB0 / Lexicon Pharmaceuticals, Inc. Bond 10,426,793 5,224,214
2017-01-20 13G/A TAL / TAL Education Group - Depositary Receipt (Common Stock) 12,038,022 10,479,065
2017-01-20 13G/A HTWR / Heartware International Inc. 1,020,308 0
2017-01-20 13G/A RGLS / Regulus Therapeutics Inc. 2,841,243 0
2016-09-02 13G/A TAL / TAL Education Group - Depositary Receipt (Common Stock) 16,029,333 12,038,022
2016-02-16 13G/A LXRX / Lexicon Pharmaceuticals, Inc. 42,605,050 10,426,793
2016-02-16 13G/A TAL / TAL Education Group - Depositary Receipt (Common Stock) 16,029,333
2016-02-16 13G RGLS / Regulus Therapeutics Inc. 2,841,243
2016-02-16 13G CYOU / Changyou.com, Ltd. 1,345,058
2016-02-16 13G HTWR / Heartware International Inc. 678,484 1,020,308
2016-02-16 13G SREV / ServiceSource International Inc 4,458,217 4,464,135
2016-02-16 13G/A CMRX / Chimerix, Inc. 3,134,923 3,425,999
2016-02-16 13G/A 528872AB0 / Lexicon Pharmaceuticals, Inc. Bond 42,605,050 10,426,793
2016-02-16 13G/A VECO / Veeco Instruments Inc. 24,299
2015-12-09 13G/A ACOR / Acorda Therapeutics, Inc. 2,922,722 4,543,009
2015-10-14 13G CMRX / Chimerix, Inc. 3,134,923
2015-10-14 13G LXRX / Lexicon Pharmaceuticals, Inc. 8,389,120 42,605,050
2015-10-14 13G/A LXRX / Lexicon Pharmaceuticals, Inc. 11,069,517
2015-06-09 13G/A ACOR / Acorda Therapeutics, Inc. 2,922,722
2015-02-13 13G/A SREV / ServiceSource International Inc 2,816,067
2015-02-13 13G TAL / TAL Education Group - Depositary Receipt (Common Stock) 13,769,064
2015-02-13 13G/A ACOR / Acorda Therapeutics, Inc. 2,675,627
2015-02-13 13G VECO / Veeco Instruments Inc. 2,070,539
2015-02-13 13G/A NIHD / NII Holdings, Inc. 6,819,865
2014-02-14 13G/A SREV / ServiceSource International Inc 8,665,528
2014-02-13 13G/A SREV / ServiceSource International Inc 8,665,528
2014-02-13 13G/A ACOR / Acorda Therapeutics, Inc. 2,613,384
2014-02-13 13G/A NIHD / NII Holdings, Inc. 14,224,403
2014-02-13 13G/A 18,094,642
2014-02-13 13G/A ATML / Atmel Corporation 745,892
2013-02-12 13G/A SREV / ServiceSource International Inc 10,651,075
2013-02-12 13G/A RVBD / 230,033
2013-02-12 13G/A ACOR / Acorda Therapeutics, Inc. 3,172,073
2013-02-12 13G/A 20,398,507
2013-02-12 13G/A ISIL / Intersil Corp. 109,994
2013-02-12 13G NIHD / NII Holdings, Inc. 12,781,135
2013-02-12 13G ATML / Atmel Corporation 26,010,028
2012-10-09 13G SREV / ServiceSource International Inc 8,857,277
2012-03-01 13G/A ACOR / Acorda Therapeutics, Inc. 3,894,016
2012-02-14 13G/A UPLMQ / Ultra Petroleum Corp. 5,271,930
2012-02-14 13G/A 21,367,524
2012-02-14 13G/A JHX / James Hardie Industries plc 18,760,301
2012-02-14 13G/A R / Ryder System, Inc. 54,495
2012-02-14 13G/A GME / GameStop Corp. 6,545,856
2012-02-14 13G/A THKLY / THK Co., Ltd. - Depositary Receipt (Common Stock) 3,925,257
2012-02-14 13G RVBD / 9,014,339
2012-02-14 13G/A ISIL / Intersil Corp. 8,947,133
2012-02-14 13G ACOR / Acorda Therapeutics, Inc. 3,585,437